New Zealand markets open in 6 hours 21 minutes

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
99.25+1.13 (+1.15%)
As of 10:39AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 37.34B
Enterprise value 30.05B
Trailing P/E 34.07
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.69
Price/book (mrq)2.20
Enterprise value/revenue 2.03
Enterprise value/EBITDA 5.54

Trading information

Stock price history

Beta (5Y monthly) 1.62
52-week change 3-19.67%
S&P500 52-week change 314.91%
52-week high 3217.25
52-week low 395.02
50-day moving average 3110.01
200-day moving average 3141.41

Share statistics

Avg vol (3-month) 33.83M
Avg vol (10-day) 34.74M
Shares outstanding 5380.59M
Implied shares outstanding 6380.59M
Float 8343.4M
% held by insiders 19.69%
% held by institutions 169.48%
Shares short (30 Aug 2023) 418.05M
Short ratio (30 Aug 2023) 44.06
Short % of float (30 Aug 2023) 46.31%
Short % of shares outstanding (30 Aug 2023) 44.74%
Shares short (prior month 30 Jul 2023) 415.77M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Jun 2023


Profit margin 11.33%
Operating margin (ttm)4.81%

Management effectiveness

Return on assets (ttm)1.34%
Return on equity (ttm)6.91%

Income statement

Revenue (ttm)10.65B
Revenue per share (ttm)27.60
Quarterly revenue growth (yoy)-92.80%
Gross profit (ttm)10.55B
Net income avi to common (ttm)1.21B
Diluted EPS (ttm)2.83
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.46B
Total cash per share (mrq)22.23
Total debt (mrq)1.17B
Total debt/equity (mrq)6.89%
Current ratio (mrq)3.39
Book value per share (mrq)44.49

Cash flow statement

Operating cash flow (ttm)-226M
Levered free cash flow (ttm)186.62M